| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |